Neuronal cell line expressing full-length mutant huntingtin exhibits alterations in proteolysis
Gotmanova, N. N.; Bobik, T. V.; Ezhov, A. A.; Rodin, V. A.; Zvereva, M. I.; Rubtsova, M. P.; Bacheva, A. V.
Show abstract
Polyglutamine diseases are incurable genetic neurodegenerative disorders characterized by the accumulation of mutant proteins with extended polyglutamine fragments, which are prone to the formation of poorly soluble aggregates. The establishment of adequate cellular models is crucial in uncovering the pathological mechanisms responsible for neurotoxicity in HD, screening for therapeutic molecules and elucidation of the molecular mechanisms impacted by particular compound. In the present study, genetic constructs based on the Sleeping Beauty system were created for the stable inducible expression of full-length normal and mutant huntingtin in eukaryotic cells. These constructs were then employed to develop model neuronal cells using Neuro-2a cell line. The expression of huntingtin as well as the accumulation of Htt-immunopositive intracellular aggregates (most characteristic features of HD) was demonstrated, and these aggregates mostly colocalized with the proteasome. The activation of the proteasome, as well as changes in the expression of proteasome regulators, components of the autophagy system, and the protease cathepsin D, reflect the versatility of cellular responses to the destructive mutant Htt pathological forms.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The DNA methyltransferase 1 (DNMT1) acts on neurodegeneration by modulating proteostasis-relevant intracellular processes 94%
- Live cell imaging of single neurotrophin receptor molecules on human neuron in Alzheimer's disease 94%
- Transcriptional and Histone acetylation changes associated with CRE elements expose key factors governing the regulatory circuit in early stage of Huntington's disease models. 93%
Similar papers in this journal
- Queuine, a bacterial derived hypermodified nucleobase, shows protection in in vitro models of neurodegeneration 95%
- Screening of Tau Protein Kinase Inhibitors in a Tauopathy-relevant cell-based model of Tau Hyperphosphorylation and Oligomerization 94%
- Iron activates microglia and directly stimulates indoleamine-2,3-dioxygenase activity in the N171-82Q mouse model of Huntington's disease 94%
Similar papers in this journal
- UBA52 is crucial in HSP90 ubiquitylation and neurodegenerative signaling during early phase of Parkinson disease 95%
- Retinoid X Receptor as a Therapeutic Target to Treat Neurological Disorders Associated with alpha-Synucleinopathy 94%
- Investigating the p21 Ubiquitin-Independent Degron Reveals a Dual Degron Module Regulating p21 Degradation and Function. 92%
Similar papers in this journal
- Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein 95%
- Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization 94%
- Mitochondrial LonP1 protease is implicated in the degradation of unstable Parkinson disease-associated DJ-1/PARK 7 missense mutants. 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.